Li Zhou

ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 6

Top Venues

Nature cancer

Analytical chemistry

Cancer research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Li Zhou, Yibing Wang, Qi Wan, Fei Wu, Jeffrey Barbon, Robert Dunstan, Stephen Gauld, Mark Konrad, Laura Leys, Richard McCarthy, Marian Namovic, Christine Nelson, Gary Overmeyer, Denise Perron, Zhi Su, Leyu Wang, Susan Westmoreland, Jun Zhang, Rui Zhu, Geertruida Veldman
A non-clinical comparative study of IL-23 antibodies in psoriasis. mAbs 13 (1) (2022)
Sarah Chan, Nicole Belmar, Sun Ho, Bryan Rogers, Marcia Stickler, Michelle Graham, Eileen Lee, Ninian Tran, Dong Zhang, Priyanka Gupta, Mien Sho, Tracy MacDonough, Andrew Woolley, Han Kim, Hong Zhang, Wei Liu, Pingping Zheng, Zoltan Dezso, Kyle Halliwill, Michele Ceccarelli, Susan Rhodes, Archana Thakur, Charles M Forsyth, Mengli Xiong, Siu Sze Tan, Ramesh Iyer, Marc Lake, Enrico Digiammarino, Li Zhou, Lance Bigelow, Kenton Longenecker, Russell A Judge, Cassie Liu, Max Trumble, Jonathan P Remis, Melvin Fox, Belinda Cairns, Yoshiko Akamatsu, Diane Hollenbaugh, Fiona A Harding, Hamsell M Alvarez
An anti-PD-1-GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy. Nature cancer 3 (3) (2022)
Darren C Phillips, Fritz G Buchanan, Dong Cheng, Larry R Solomon, Yu Xiao, John Xue, Stephen K Tahir, Morey L Smith, Haichao Zhang, Deborah Widomski, Vivek C Abraham, Nan Xu, Zhihong Liu, Li Zhou, Enrico DiGiammarino, Xin Lu, Nandini Rudra-Ganguly, Bruce Trela, Susan E Morgan-Lappe
Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors. Cancer research 81 (12) (2021)
Zhi-Fu Tao, Xilu Wang, Jun Chen, Justin P Ingram, Sha Jin, Russell A Judge, Peter J Kovar, Chang Park, Chaohong Sun, Brian D Wakefield, Li Zhou, Haichao Zhang, Steven W Elmore, Darren C Phillips, Andrew S Judd, Joel D Leverson, Andrew J Souers
Structure-Based Design of A-1293102, a Potent and Selective BCL-XL Inhibitor. ACS medicinal chemistry letters 12 (6) (2021)
Sun K Ho, Zhenghai Xu, Archana Thakur, Melvin Fox, Siu Sze Tan, Enrico DiGiammarino, Li Zhou, Mien Sho, Belinda Cairns, Vivian Zhao, Mengli Xiong, Josue Samayoa, Charles M Forsyth, David B Powers, Debra T Chao, Diane Hollenbaugh, Hamsell M Alvarez, Yoshiko Akamatsu
Epitope and Fc-Mediated Cross-linking, but Not High Affinity, Are Critical for Antitumor Activity of CD137 Agonist Antibody with Reduced Liver Toxicity. Molecular cancer therapeutics 19 (4) (2020)
Li Zhou, Jun Zhang, Enrico DiGiammarino, Amol Kavishwar, Bo Yan, Chris Chumsae, Peter M Ihnat, David Powers, John Harlan, William Blaine Stine
PULSE SPR: A High Throughput Method to Evaluate the Domain Stability of Antibodies. Analytical chemistry 90 (20) (2018)

Li Zhou.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Li Zhou